Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Osiris Therapeutics Inc

+ Add to Watchlist

OSIR:US

16.1300 USD 0.6900 4.10%

As of 20:10:00 ET on 01/30/2015.

Snapshot for Osiris Therapeutics Inc (OSIR)

Open: 16.7500 Day's Range: 16.1200 - 16.8900 Volume: 145,475
Previous Close: 16.8200 52wk Range: 11.8004 - 17.6000 1-Yr Rtn: +3.33%

Stock Chart for OSIR

No chart data available.
  • OSIR:US 16.1300
  • 1D
  • 1M
  • 1Y
16.8200
Interactive OSIR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OSIR

Current P/E Ratio (ttm) 274.9697
Estimated P/E(12/2014) -
Relative P/E vs. SPX 15.6522
Earnings Per Share (USD) (ttm) 0.0587
Est. EPS (USD) (12/2014) -0.0170
Est. PEG Ratio -
Market Cap (M USD) 553.58
Shares Outstanding (M) 34.32
30 Day Average Volume 141,616
Price/Book (mrq) 6.7415
Price/Sale (ttm) 11.3446
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OSIR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OSIR

Osiris Therapeutics, Inc. researches and develops therapeutic products for the regeneration of human connective tissues. The Company is focusing its initial product development efforts on the regeneration of bone marrow stroma following high-dose cancer chemotherapy, and on the regeneration of bone in long bone and spinal defects.

Lode DebrabanderePresident/CEOPhilip R Jacoby JrCFO/Treasurer/Secretary
Jonathan M Hopper "Jon"Chief Medical OfficerFrank D Czworka JrVP/General Manager:Wound Care
More Company Profile & Key Executives for OSIR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil